Kenya to roll out long-acting injectable HIV PrEP Lenacapavir by Jan 2026 » Capital News

NAIROBI, Kenya, Jul 15 – Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following its approval by the World Health Organization. In a statement, Health Cabinet Secretary Aden Duale stated that…